Variations in infection sites and mortality rates among patients in intensive care units with severe sepsis and septic shock in Japan by 杉山 雄大 et al.
Variations in infection sites and mortality
rates among patients in intensive care units
with severe sepsis and septic shock in Japan
著者（英） Toshikazu Abe, Hiroshi Ogura, Shigeki
Kushimoto, Atsushi Shiraishi, Takehiro
SUGIYAMA, Gautam A. Deshpande, Masatoshi
Uchida, Isao Nagata, Daizoh Saitoh, Seitaro
Fujishima, Toshihiko Mayumi, Toru Hifumi,
Yasukazu Shiino, Taka-aki Nakada, Takehiko
Tarui, Yasuhiro Otomo, Kohji Okamoto, Yutaka
Umemura, Joji Kotani, Yuichiro Sakamoto,
Junichi Sasaki, Shin-ichiro Shiraishi,
Kiyotsugu Takuma, Ryosuke Tsuruta, Akiyoshi
Hagiwara, Kazuma Yamakawa, Tomohiko Masuno,
Naoshi Takeyama, Norio Yamashita, Hiroto
Ikeda, Masashi Ueyama, Satoshi Fujimi, Satoshi
Gando
journal or
publication title
Journal of Intensive Care
volume 7
number 28
year 2019-05
権利 (C) The Author(s). 2019 Open Access This
article is distributed under the terms of the
Creative Commons Attribution 4.0 International
License
(http://creativecommons.org/licenses/by/4.0/),
which permits unrestricted use, distribution,
and reproduction in any medium, provided you
give appropriate credit to the original
author(s) and the source, provide a link to
the Creative Commons license, and indicate if
changes were made. The Creative Commons Public
Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/
1.0/) applies to the data made available in
this article, unless otherwise stated.
Creative Commons : 表示
http://creativecommons.org/licenses/by/3.0/deed.ja
URL http://hdl.handle.net/2241/00157741
doi: 10.1186/s40560-019-0383-3
Creative Commons : 表示
http://creativecommons.org/licenses/by/3.0/deed.ja
RESEARCH Open Access
Variations in infection sites and mortality
rates among patients in intensive care units
with severe sepsis and septic shock in
Japan
Toshikazu Abe1,2,30*, Hiroshi Ogura3, Shigeki Kushimoto4, Atsushi Shiraishi5, Takehiro Sugiyama2,6,30,
Gautam A. Deshpande1, Masatoshi Uchida2, Isao Nagata2, Daizoh Saitoh7, Seitaro Fujishima8, Toshihiko Mayumi9,
Toru Hifumi10, Yasukazu Shiino11, Taka-aki Nakada12, Takehiko Tarui13, Yasuhiro Otomo14, Kohji Okamoto15,
Yutaka Umemura3, Joji Kotani16, Yuichiro Sakamoto17, Junichi Sasaki18, Shin-ichiro Shiraishi19, Kiyotsugu Takuma20,
Ryosuke Tsuruta21, Akiyoshi Hagiwara22, Kazuma Yamakawa23, Tomohiko Masuno24, Naoshi Takeyama25,
Norio Yamashita26, Hiroto Ikeda27, Masashi Ueyama28, Satoshi Fujimi23, Satoshi Gando29,31 and on behalf of JAAM
FORECAST group
Abstract
Background: Accurate and early identification of infection sites might help to drive crucial decisions regarding the
treatment of sepsis. We aimed to determine the clinical and etiological features of infection according to sites
among patients with severe sepsis in Japan.
Methods: This secondary analysis of a multicenter, prospective cohort study included 59 intensive care units (ICU)
and proceeded between January 2016 and March 2017. The study cohort comprised 1184 adults (≥ 16 years) who
were admitted to an ICU with severe sepsis and septic shock diagnosed according to the sepsis-2 criteria. Sites of
infection diagnosed by physicians in charge at the time of arrival comprised the lung, abdomen, urinary tract, soft
tissue, bloodstream, central nervous system (CNS), and undifferentiated infections. The primary outcome was in-
hospital mortality.
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Results: The most common sites of infection were the lungs (31.0%), followed by intra-abdominal sites (26.3%), the
urinary tract (18.4%), and soft tissue (10.9%). The characteristics of the patients with severe sepsis across seven major
suspected infection sites were heterogeneous. Septic shock was more frequent among patients with intra-abdominal
(72.2%) and urinary tract (70.2%) infections than other sites. The in-hospital mortality rate due to severe sepsis and
septic shock of a pooled sample was 23.4% (range, 11.9% [urinary tract infection] to 47.6% [CNS infection]). After
adjusting for clinical background, sepsis severity, and stratification according to the presence or absence of shock,
variations in hospital mortality across seven major sites of infection remained essentially unchanged from those for
crude in-hospital mortality; adjusted in-hospital mortality rates ranged from 7.7% (95%CI, − 0.3 to 15.8) for urinary tract
infection without shock to 58.3% (95%CI, 21.0–95.7) for CNS infection with shock in a generalized estimating equation
model. Intra-abdominal and urinary tract infections were statistically associated with less in-hospital mortality than
pneumonia. Infections of the CNS were statistically associated with higher in-hospital mortality rates than pneumonia
in a logistic regression model, but not in the generalized estimating equation model.
Conclusions: In-hospital mortality and clinical features of patients with severe sepsis and septic shock were
heterogeneous according to sites of infection.
Keywords: Heterogeneity, Survival, Therapy, Sepsis, Infection
Introduction
Sepsis remains a major lethal healthcare problem,
with a reported mortality of > 25% [1]. Sepsis differs
from straightforward infection in that it is associated
with life-threatening organ dysfunction, multiple
organ failure, and death due to a dysregulated host
response to infection [2]. The pathology of sepsis
involves both inflammatory and anti-inflammatory
responses [3, 4] and includes a broad spectrum of
conditions with various clinical manifestations and
patterns of acute organ dysfunction. From a clinical
viewpoint, the history and characteristics of patients,
infection sites, and comorbidities are remarkably
heterogeneous. This, together with confusing nomen-
clature describing this syndrome and the scarcity of
appropriate epidemiological data, has contributed to
suboptimal findings from observational studies of
sepsis [5–7].
Some authors have suggested that understanding clin-
ical differences based on infection sites could aid clini-
cians to appropriately stratify risk, help guide clinical
decisions regarding treatment, and facilitate understand-
ing of variations in host responses [8, 9]. However, few
studies have described differences in clinical characteris-
tics and in-hospital mortality based on infection sites that
might be important [6, 7]. Although our previous Focused
Outcomes Research in Emergency Care in Acute Respira-
tory Distress Syndrome, Sepsis, and Trauma (FORE-
CAST) study [10] determined management and clinical
outcomes among patients with severe sepsis and septic
shock in Japan, clinical features according to infection
sites have not yet been evaluated. Therefore, the present
study aimed to identify the clinical and etiological features
and outcomes of severe sepsis based on infection sites to
help guide clinical decisions.
Methods
Design, setting, and participants
This is a secondary analysis of a sub-study of patients
with severe sepsis in the multicenter prospective cohort
FORECAST study of acutely ill patients at 59 ICU in
Japan that proceeded between January 2016 and March
2017 [10]. We investigated data from adult patients (≥
16 years) diagnosed with severe sepsis based on the 2003
sepsis-2 criteria [11]. Inclusion criteria comprised the
new onset of suspected infection based on clinical his-
tory, at least two systemic inflammatory response syn-
drome (SIRS) criteria, and evidence of dysfunction in at
least one organ [11]. Exclusion criteria comprised requir-
ing sustained life support or being in
post-cardiopulmonary arrest resuscitation status when
sepsis was diagnosed.
Data collection
Data were obtained from a database compiled by the
FORECAST investigators. The variable of primary inter-
est was the site of infection. Other variables included pa-
tient information such as demographics, admission
source, comorbidities, activities of daily life (ADL) status,
organ dysfunction, infection characteristics, laboratory
data, blood culture findings, and antibiotics (no informa-
tion was available about the amount and duration). Data
were inputted by FORECAST investigators throughout
the periods that patients remained in hospital. The pri-
mary outcome was in-hospital mortality.
Data definitions
Septic shock and organ dysfunction were defined ac-
cording to the sepsis-2 criteria [11]. Sites of infection
were assessed as suspected at initial examination by phy-
sicians in charge because the initial diagnosis contributes
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to predicting outcome [6, 7]. Sites of infection in this
database initially included the lungs, intra-abdominal
sites (the peritoneum, the pancreas, the gall bladder, the
bowel, and other sites), urinary tract, soft tissue, wounds,
osteo-articular sites, endocardium, and catheter-related,
implant device-related, central nervous system (CNS),
and undifferentiated infection (Additional file 1: Table
S1). Because several categories contained few patients,
we consolidated them into seven major categories com-
prising the lungs, intra-abdomen, urinary tract, soft tis-
sue (including wounds), and bloodstream-related, CNS,
and undifferentiated infection.
Analysis
Descriptive statistics included counts (proportions) for cat-
egorical variables, and continuous variables are expressed
as medians with interquartile ranges (IQR) because many
variables were not normally distributed. Data were not ad-
justed unless specifically stated otherwise. Since few values
were missing, assumptions were not made for missing
data; these are noted as footnotes to tables.
We compared the baseline characteristics of the pa-
tients, demographic data, infection characteristics in-
cluding results of blood cultures, sepsis severity, organ
dysfunction, and mortality outcomes categorized by in-
fection sites. We also described the frequency and choice
of initial antibiotics administered. We then stratified
crude in-hospital mortality rates by sites of infection and
the presence of shock because clinical approaches such
as resuscitation differed between patients with and with-
out shock. We adjusted the backgrounds of the patients
and sepsis severity considering clustering by ICU using
generalized estimating equation (GEE) models with an
independent working correlation matrix. Models were
adjusted for age, sex, Charlson comorbidity index (CCI),
and organ-specific sepsis-related organ failure assess-
ment (SOFA) scores and were selected a priori based on
reported findings [6, 7] and clinical importance. We then
used marginal standardization [12] based on probability
determined from the GEE model to estimate adjusted
in-hospital mortality by the seven major infection sites.
To determine the clinical relationship between infection
sites and shock, these models were further stratified by
the presence or absence of shock. Results are reported
as adjusted in-hospital mortality rates with 95% confi-
dence intervals (CI). We assessed each variable for mul-
ticollinearity and also compared in-hospital mortality
rates among the seven major infection sites using logistic
regression as a sensitivity analysis. Models were adjusted
for age, sex, BMI, ADL, admission sources, Charlson
comorbidity index (CCI), presence of shock, and organ-
specific SOFA scores, then further stratified by the pres-
ence of shock. The lungs served as the reference for all
statistical models as they comprised the most frequent
sites of infection.
All p values were two-sided, with p < 0.05 being con-
sidered statistically significant. Data were statistically an-
alyzed using SPSS software, version 23.0 (IBM, Armonk,
NY, USA) and Stata software, version 14.2 (StataCorp,
College Station, TX, USA).
Results
Patients’ characteristics
We analyzed data from 1184 patients with severe sepsis
who met the inclusion and exclusion criteria at 59 partici-
pating ICU in Japan between January 2016 and March
2017. The median age was 73 (IQR, 64–81) years and
60.7% were male. Most (57.1%) patients with severe sepsis
arrived directly from emergency departments (ED), fewer
were transferred from other departments or were diag-
nosed with severe sepsis while in an ICU, and 62.9% of pa-
tients were diagnosed with septic shock on arrival. The rate
of blood culture positivity upon admission was 54.0%.
Patients were categorized by infection site upon arrival
(Table 1). The most common site of infection was the
lungs (31.0%), followed by the intra-abdomen (26.3%), the
urinary tract (18.4%), and soft tissue (10.9%). The charac-
teristics of the patients with severe sepsis were heteroge-
neous across all seven infection sites. Septic shock was
more frequent among patients with intra-abdominal
(72.2%) and urinary tract (70.2%) infections. Patients with
lung, CNS, and undifferentiated infections had high APA-
CHE II scores. Organ-specific SOFA scores were hetero-
geneous, but total scores were relatively similar. Rates of
blood culture positivity were > 80% in bloodstream-related
(osteo-articular 81.0%, endocardial 81.3%, catheter-related
90.9%, and implant device-related 87.5%) infections (Add-
itional file 1: Table S1). Gram-negative rods were most fre-
quently identified in cultured blood from intra-abdominal
and urinary tract sites, whereas Gram-positive cocci were
prevalent at other sites of infection (Additional file 2:
Table S2). Fungal infection was rarely found in blood cul-
tures. With respect to organ dysfunction, hypotension and
hyperlactatemia were equally prevalent among patients
with shock (Additional file 2: Table S2). Hyperlactatemia
was prevalent (69.6%) among patients with CNS infection,
although the rate of shock was relatively low (30.4%). The
prevalence of thrombocytopenia was 43.5% and 55.1% in
CNS and undifferentiated infections, respectively.
Carbapenem was the most frequent initial antibiotic
(55.0%), followed by tazobactam/piperacillin (PIPC/
TAZ) (20.9%) (Table 1). Carbapenem was usually admin-
istered to patients with intra-abdominal, urinary tract,
and soft tissue infections (61.3%, 59.6%, and 63.7%, re-
spectively), whereas bloodstream and CNS infections
were usually treated with vancomycin (VCM; 47.8% and
63.6%, respectively) (Additional file 3: Table S3). Most
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(63.2%) patients received antibiotic monotherapy, particu-
larly those with intra-abdominal (79.8%) or urinary tract
(77.5%) infections, whereas those with soft tissue, blood-
stream, and CNS infections more frequently received com-
bined antibiotics (66.9%, 62.7%, and 72.7%, respectively).
Outcomes
Mortality follow-up data were available for 97.0% of pa-
tients during their hospitalization. The overall in-hospital
mortality rate was 23.4%. Regardless of shock status, crude
in-hospital mortality ranged from 11.9 to 47.6% (urinary
tract infection and CNS infection, respectively) across all
sites of infection (Fig. 1; Additional file 1: Table S1). After
stratification by the presence or absence of shock, crude
in-mortality values ranged from 9.2% (urinary tract infec-
tion without shock) to 57.1% (CNS infection with shock)
(Fig. 1). After adjusting for clinical background and sepsis
severity, variations in hospital mortality across the seven
major sites of infection remained essentially unchanged
from those for crude in-hospital mortality; adjusted
in-hospital mortality ranged from 7.7% (95%CI, − 0.3 to
15.8) for urinary tract infection without shock to 58.3%
(95%CI, 21.0–95.7) for CNS infection with shock in a gen-
eralized estimating equation model (Fig. 1). Adjusted mor-
talities and its 95% confidence interval calculated by the
generalized estimating equation model are demonstrated;
those for pneumonia were 28.8% (95%CI, 21.4–36.2) in all,
33.9% (95%CI, 25.1–42.6) with shock, and 19.6% (95%CI,
11.4–27.8) without shock; those for CNS infection were
48.7% (95%CI, 25.7–71.7) in all, 58.3% (95%CI, 21.0–95.7)
with shock, and 32.7% (95%CI, 5.8–59.7) without shock;
and those for undifferentiated infection were 32.4%
Table 1 Characteristics of patients with sepsis and major infection sites (n = 1184)
Characteristics All Sites
Lung Intra-abdomen Urinary tract Soft tissue Bloodstream CNS Undifferentiated
1184 367 (31.0) 311 (26.3) 218 (18.4) 129 (10.9) 67 (5.7) 23 (1.9) 69 (5.8)
Age at admission (years) 73 (64–81) 73 (65–80) 74 (66–83) 74 (63–83) 67 (58–78) 69 (57–81) 69 (63–84) 69 (58–75)
Male sex 719 (60.7) 263 (71.7) 191 (61.4) 94 (43.1) 80 (62.0) 36 (53.7) 15 (65.2) 40 (58.0)
BMI (kg/m2) 22 (19–25) 22 (19–25) 21 (19–24) 22 (19–25) 23 (21–26) 22 (19–23) 23 (21–25) 24 (20–25)
ADL (Inactive) 288 (24.3) 82 (22.3) 60 (19.4) 82 (37.6) 29 (22.7) 22 (32.8) 1 (4.3) 12 (17.9)
Charlson comorbidity index 1 (0–2) 2 (0–3) 1 (0–2) 1 (0–2) 1 (0–2) 1 (0–2) 1 (1–2) 1 (1–3)
Admission source
ED 676 (57.2) 226 (61.6) 158 (51.1) 147 (67.4) 67 (51.9) 32 (47.8) 12 (52.2) 34 (49.3)
Non-ED
(transfer or other department)
457 (38.7) 131 (35.7) 134 (43.4) 68 (31.2) 55 (42.6) 31 (46.3) 7 (30.4) 31 (44.9)
ICU 49 (4.1) 10 (2.7) 17 (5.5) 3 (1.4) 7 (5.4) 6 (6.0) 4 (17.4) 4 (5.8)
Septic Shock 745 (62.9) 197 (53.7) 226 (72.2) 153 (70.2) 75 (58.1) 41 (61.2) 7 (30.4) 46 (66.7)
Positive blood culture 636 (54.0) 133 (36.4) 154 (49.8) 160 (73.7) 75 (58.1) 57 (85.1) 16 (72.7) 41 (60.3)
APACHE II score 23 (17–29) 25 (18–31) 21 (16–28) 22 (17–27) 22 (15–28) 21 (17–30) 27 (20–33) 26 (18–34)
SOFA score
All 9 (6–11) 9 (5–12) 9 (6–11) 9 (6–11) 8 (5–11) 8 (6–11) 9 (7–11) 10 (7–13)
Respiratory 2 (1–2) 2 (2–3) 2 (1–2) 2 (1–2) 2 (1–2) 1 (0.3–2) 1 (1–2) 2 (1–2)
Cardiovascular 3 (0–4) 2 (0–4) 3 (1–4) 3 (0–4) 3 (0–4) 2.5 (0–4) 0 (0–4) 0 (0–3)
Hepatic 0 (0–1) 0 (0–1) 0 (0–2) 0 (0–2) 0 (0–1) 0 (0–1.8) 0 (0–1) 0 (0–2)
Coagulation 1 (0–2) 0 (0–1) 1 (0–1) 1 (0–2) 1 (0–2) 1 (0–2) 1 (0–2) 2 (0–3)
Renal 1 (0–3) 1 (0–3) 1 (0–3) 2 (1–3) 2 (0–3) 2 (0–3) 1 (1–2) 2 (0.3–3.8)
Neurological 1 (0–3) 1.5 (0–3) 1 (0–2) 1 (0–3) 1 (0–2) 1 (0–2) 3 (2–3) 1 (0–3)
Broad spectrum antibiotics
Carbapenem 627 (55.0) 159 (45.0) 182 (61.3) 127 (59.6) 79 (63.7) 30 (44.8) 10 (45.5) 40 (62.5)
PIPC/TAZ 238 (20.9) 85 (24.1) 59 (19.9) 52 (24.4) 20 (16.1) 16 (23.9) 0 (0) 6 (9)
Reported counts (proportions) of categorical and medians (interquartile range) for continuous variables. Missing data: BMI, n = 26; admission source, n = 2; APACHE
II score, n = 16; SOFA score, n = 183
ADL activities of daily living, APACHE acute physiology and chronic health evaluation, BMI body mass index, ED emergency department, SIRS systemic
inflammatory response syndrome, SOFA sepsis-related organ failure assessment
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(95%CI, 23.5–41.4) in all, 43.1% (95%CI, 29.6–56.6) with
shock, and 14.1% (95%CI, 1.2–27.1) without shock.
Intra-abdominal infections were statistically associated with
lower in-hospital mortality rates than pneumonia in the lo-
gistic regression model (P = 0.03) but not in the GEE model
(P = 0.10). Urinary tract infections were statistically associ-
ated with lower in-hospital mortality rates than pneumonia
in the logistic model and in the GEE model (P < 0.01).
Infections of the CNS were statistically associated with
higher in-hospital mortality rates than pneumonia in the
logistic regression model (P = 0.04), but not in the GEE
model (P = 0.07). Multicollinearity was not observed in the
GEE model and the logistic regression model; all variance
inflation factors were less than 3. After stratification by
shock, variations in in-hospital mortality according to sites
of infection persisted in patients with septic shock but not
in those with non-septic shock (Figs. 1 and 2).
Discussion
Brief summary
The multicenter, prospective FORECAST cohort study of
patients with severe sepsis at 59 ICU in Japan confirmed
that severe sepsis is a heterogeneous clinical syndrome
that is associated with a poor prognosis. More import-
antly, highly variable in-hospital mortality was associated
with infection sites, especially among patients with shock.
Heterogeneity of severe sepsis
The variation in severe sepsis was associated with infection
sites and shock. After adjustment for initial characteristics
and severity, intra-abdominal or urinary tract infections
were associated with lower mortality rates than other sites
of infection, but such patients were more likely to have
shock. Our results were relatively consistent with these
findings [6, 7], which was reasonable because patients with
Fig. 1 Crude and adjusted in-hospital mortality rates for patients with sepsis according to seven major infection sites stratified by shock. The
crude mortalities are summarized in the table and adjusted mortalities and its 95% confidence interval calculated by the generalized estimating
equation model are demonstrated with a bar graph with error bars.Data were adjusted for age, sex, Charlson comorbidity index, and organ-
specific sepsis-related organ failure assessment (SOFA) scores using marginal standardization. CNS central nervous system
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intra-abdominal or urinary tract infections often had stone
pyelonephritis, cholangitis, or cholecystitis, namely, source-
controllable infections [9]. On the other hand, mortality
associated with intra-abdominal infection varied, which
might be due to the wide heterogeneity of intra-abdominal
infections such as peritonitis, pancreatitis, cholangitis, and
ischemic bowel infections [6]. Mortality rates were the
highest among patients with CNS infection and septic
shock, but the statistical significance was not clear. Only 23
of 1184 patients with CNS infection were admitted to an
ICU, and they were less likely to have shock (n = 7 of 23).
This might have been underpowered due to the small
patient cohort. Otherwise, selection bias might have been
involved. Bloodstream and undifferentiated infections
might have been also involved in the same discussion as
CNS infection. Moreover, the GEE model was used as the
main analysis instead of the logistic regression model
because the prevalence of site of infection in sepsis and pa-
tient’s severity was considered to be clustered by facility,
that is, the ordinal logistic regression model could be too
efficient, whereas the point estimate from the logistic
regression was consistent with that from the GEE model
with an independent working correlation matrix. The
present results which showed intra-abdominal and CNS in-
fections showed contradictory results about a significance
between the GEE model and the logistic regression model.
It implied that the severity of intra-abdominal and CNS
infections in each ICU was various. Otherwise, it could
have needed more samples to show a significance. Previous
studies have not found an association between positive
blood cultures and mortality outcomes but have associated
prognosis more closely with the severity of sepsis rather
than the severity of underlying infection [13, 14]. More
patients in the present study with infections of the urinary
Fig. 2 Relationship between seven major sites of infection and in-hospital mortality among all patients with severe sepsis (n = 952), and those
with (n = 613) and without (n = 339) septic shock using logistic regression models. Data were adjusted for age, sex, BMI, ADL, admission sources,
CCI, presence of shock, and organ-specific SOFA scores. ADL, activities of daily living; BMI, body mass index; CCI, Charlson comorbidity index; CI,
confidence interval; CNS, central nervous system; SOFA, sepsis-related organ failure assessment
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tract (major infection site) also had bacteremia, but the
mortality rate was lower than that for other infections.
Prognosis might have been associated with the distribution
of infection sites in patients with bacteremia in each study.
Septic shock in 63% of the patients in the present
study was associated with 28% in-hospital mortality,
which was lower than previously published rates [6]. A
systematic review identified a crude mortality rate asso-
ciated with septic shock of 47% [15]. The present study
found at least 40% mortality when septic shock was as-
sociated with the lungs, CNS, and undifferentiated infec-
tions. Although mortality rates are high among patients
with septic shock, our findings emphasized the potential
contribution of infection sites to mortality. The particu-
lar distribution of infection sites and shock might have
contributed to the mortality rates in the present study.
The contributing influence of infection sites among
patients without shock was not clear. Point estimates of
odds ratios according to sites of infection were similar
despite the presence of shock in most patients, suggest-
ing that the effect of the infection site on mortality was
independent of shock. The number of patients without
shock may have been insufficient to discern a statistical
difference in mortality rates between those with and
without shock. Otherwise, mortality rates might not
differ according to infection sites among patients
without shock. Validation studies with a larger sample
size are needed to confirm our findings.
Possible explanations and implications
We found wide clinical heterogeneity regarding infection
sites in patients with severe sepsis and septic shock. This
highlights the importance of early and accurate diagnosis
of infection sites, with the ability to diagnose warranting
equivalent consideration of the skill required to select
optimal treatment strategies [8]. By analogy, our findings
suggested that because sepsis is not a monolithic disease,
the approach should perhaps follow strategies more
commonly found in oncology [16]. For example, cancer
is uniform in the sense of dysregulated cell growth with
distant invasion potential [17], but cancer treatment is
now increasingly based on targeted cell receptors and is
rapidly moving away from a chemotherapy-for-all
paradigm [8]. The present findings imply that increased
focus on specific organ-system presentation, namely,
“sepsis at the infection source,” with appropriate subse-
quent risk stratification and diagnosis could be a reason-
able strategy. Our results might contribute to similar
profiling of infection sites, which we believe will be an
important frontier of future sepsis research [8]. More-
over, differences of outcome according to the source
infection are important to be considered in future
randomized control trials in sepsis and septic shock.
Limitations
Several limitations of this study warrant discussion. First,
the observational design of the study caused difficulties
distinguishing causative from correlational relationships.
Causal influence requires statistical evaluation, but clin-
ical implications should also be considered. Second, we
based our profile classification on suspected sites of in-
fection at the time of admission, rather than on defini-
tive sites of infection. Some patients might have been
misdiagnosed, and our results suggest that the conse-
quences of this impact patient outcomes. However, most
infection sites were clarified from culture findings
(Additional file 2: Table S2). Third, we consolidated 11
initial sites of infection into seven. This might have gen-
erated some bias but avoided overcomplexity. Fourth,
we enrolled fewer patients than expected during con-
secutive sampling. The reasons for this were as follows.
The prevalence of sepsis is relatively lower in tertiary
care centers in Japan (< 5% in the 2010–2011 sepsis
registry [18]). Some institutions became involved in the
FORECAST study well after it began. Other institutions
may have obtained convenience samples even though we
had planned consecutive enrolment in the FORECAST
study. Fifth, although our data were derived from a large
database compiled from 59 ICU, all patients were diag-
nosed and treated in Japan. Therefore, epidemiological
patterns of infection sites and microorganisms might be
localized. We studied only patients who were admitted
to ICU. Sixth, patients with CNS or soft tissue infections
were more likely to be admitted to wards instead of ICU
because they were less likely to have shock. Seventh,
SSCG 2016 has provided updated definitions and clinical
criteria for sepsis (sepsis-3) [2, 15, 19]. Nonetheless, ap-
plication to the clinical settings would not be difficult
due to the large overlap in sepsis-3 and sepsis-2 defini-
tions. Finally, we do not have information about the
amount of time that elapsed between the initiation of sepsis
and ICU admission, and this might have been associated
with outcomes. We also do not have information about
source control. However, we believe that all the patients re-
ceived appropriate source control because all participating
institutions are nationally certified emergency centers.
Conclusions
We found that in-hospital mortality and the clinical fea-
tures of patients with severe sepsis and septic shock
were heterogeneous according to sites of infection.
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